These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27845158)

  • 1. The application of nanoparticles in diagnosis and theranostics of gastric cancer.
    Li R; Liu B; Gao J
    Cancer Lett; 2017 Feb; 386():123-130. PubMed ID: 27845158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Cancer Imaging with Polymeric Nanoassemblies: From Tumor Detection to Theranostics.
    Mi P; Wang F; Nishiyama N; Cabral H
    Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27739631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation nanotheranostics targeting cancer stem cells.
    Reda A; Hosseiny S; El-Sherbiny IM
    Nanomedicine (Lond); 2019 Sep; 14(18):2487-2514. PubMed ID: 31490100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal nanoparticles: a theranostic nanotool against cancer.
    Sharma H; Mishra PK; Talegaonkar S; Vaidya B
    Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
    Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
    Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer.
    Sawaki K; Kanda M; Kodera Y
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):657-670. PubMed ID: 29902383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
    Chen Q; Liu Z
    Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
    Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
    Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment.
    Li K; Dan Z; Nie YQ
    World J Gastroenterol; 2014 May; 20(18):5420-6. PubMed ID: 24833872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
    Patra CR
    Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future biomarkers in gastric cancer.
    Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
    Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
    Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
    Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
    Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
    Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies.
    Majeed W; Iftikhar A; Khaliq T; Aslam B; Muzaffar H; Atta K; Mahmood A; Waris S
    Asian Pac J Cancer Prev; 2016; 17(7):3053-60. PubMed ID: 27509928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic molecular imaging of early gastric cancer using fluorescently labeled human H-ferritin nanoparticle.
    Du Y; Fan K; Zhang H; Li L; Wang P; He J; Ding S; Yan X; Tian J
    Nanomedicine; 2018 Oct; 14(7):2259-2270. PubMed ID: 30056091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.